U.S., Nov. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07222995) titled 'Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs' on Oct. 28.
Brief Summary: The purpose of this study is to examine how different messages about risk of skin cancer can impact the uptake of skin cancer prevention activities.
Study Start Date: Oct. 10
Study Type: INTERVENTIONAL
Condition:
Skin Cancer
Intervention:
BEHAVIORAL: Precision Prevention Booklet
Precision prevention booklet anchored in their MC1R risk that incorporates gold-standard risk communication strategies, including visual risk representations and simple language.
BEHAVIORAL: Standard Prevention Booklet
Stand...